
MSF and groups call for end to Gilead’s unwarranted hepatitis C grug monopoly in Europe
Gilead’s price gouging for Sofosbuvir blocks millions of people from getting treatment Munich/Paris/New York – This week in Munich, the European Patent Office is hearing a legal challenge filed by groups in 17 countries in March